Nearly two decades of excellent work have built an outstanding reputation in the field of biotechnology. The time and effort that he has put into his work has payed off with benefits to mankind. As an entrepreneur who has founded more than forty companies including ones in the biotechnology and pharmaceutical realms, Dr. Rosenwald has raised over a billion dollars to further research in these areas as well.
Lindsay Rosenwald became known for his work in the financial sector as an investment banker, venture capitalist, and hedge fund manager.Dr. Lindsay Rosenwald got his interest in biotechnology fueled from his first company. This interest stems from his belief that smaller biotechnology companies are going to be the ones making he largest advances in future research. His financing of these smaller companies has helped them to make a positive impact upon the world.
Dr. Rosenwald studied at Pennsylvania State University after his graduation in 1973 from Abington High School, also in Pennsylvania. While at Pennsylvania State he was in the business school honor society of Beta Gamma Sigma. After graduation from Pennsylvania State in 1977, Lindsay took his Bachelors of science in finance degree and entered into Temple University for studying in the medical field. In 1983 he graduated Temple University School of Medicine with his medical degree.
Dr. Rosenwald then began his career in medicine, he took an internship at Abington Hospital in 1984.After completion of his internship, Lindsay entered into private and remained there until 1986 when he moved to Wall Street as an analyst and physician. The leap that Lindsay took was a bit of an unusual one for that time period.
Dr. Lindsay Rosenwald founded the group of companies in 1991. which finances small biotechnology companies in their research and growth.They give these smaller biotechnology companies a chance to grow by providing finances for start-ups and product development. They have had dramatic growth since its founding which are investment and development companies to promote the research and product development within the groups portfolio companies.
Dr. Rosenwald’s companies are well known to the world of scientific research as they have brought substantial product developments to the world. The first gene therapy and cancer vaccine company to become publicly traded was one of his. Of the companies who obtain FDA approval for drugs, one of Dr. Rosenwald’s has the record for fastest FDA approval in the United States for Arsenic Trioxide, a leukemia drug which went thru the approval process within thirty months. Cougar Biotechnology, the only company to be sold with just one product which is yet to be approved by the FDA, is one of Dr. Rosenwald’s founded companies. It was bought in 2009 by Johnson and Johnson for one billion dollars. The drug that was developed there was a treatment for prostate cancer.
Among several other biotechnology companies Dr. Rosenwald has founded which are making breakthroughs is Cypress Bioscience. They have developed many advanced drugs including Savella which is used to treat fibromyalgia and a medical device for treating severe rheumatoid arthritis, the Prosorba Column. Very important advancements considering the amount of pain and suffering that these two diseases cause to millions of people around the world. Another of hios companies, Polarx created a leukemia drug called Trisinox used to treat acute cases. Biocryst Pharmaceuticals, another of Dr. Rosenwald’s endeavors, won worldwide approval for it’s H1N1 influenza drug Peramivir. Also, Titan Pharmaceuticals received FDA approval for Fanapt, used in the treatment of schizophrenia. Another particular health issue for which Dr. Rosenwald’s companies have created drugs for is obesity. This being one of the best of developments in the past thirty years for the treatment of obesity, which is so prevalent in the United States.
Dr. Lindsay Rosenwald’s contribution to the betterment of peoples lives doesn’t just include his companies research and drug development, but also in philanthropy. He actively donates to his own and other companies for the improvement of mankind’s health. The Rosenwald Foundation, which promotes education in the fields of science and medicine, donates millions of dollars to various educational institutions who specialize in these areas including those who conduct research as well.
Dr. Rosenwald is the director of several companies in the private and public sectors including Interneuron Pharmaceuticals Inc., Keryx Inc., and Neose Technologies. He is also among those on the board of directors for the Jewish Republican Coalition as well as being on the advisory council for Columbia-Presbyterian Health Sciences Advisory Council. The goal of the Jewish Republican Coalition is to bridge a gap that might be felt between the Jewish and political communities in America. They accomplish this by the intermingling of the Jewish community with the Republican officials who serve in the American political offices. The Columbia-Presbyterian Advisory Council is responsible for the decisions made by the Columbia University College of Physicians and Surgeons. Dr. Rosenwald is able to provide a great service to not only the biotechnology field, but humanity by the service he gives by occupying these positions.
Throughout Dr. Rosenwald’s years of service, as a medical practitioner and a company fonder as well as philanthropist, he has helped mankind live better and more productive lives. He is an important part of many biotechnology corporations and he is still investing in methods and research to help people in the treatment of life threatening and disabling diseases.
